Funding Received
$1 Million in 1 Round from 1 Investor
Most Recent Funding
$1 Million on January 1, 2007 / Undisclosed Round
Headquarters:
San Diego, CA
Description:
RegeneMed develops drugs by providing integrated, high-throughput platforms incorporating engineered human tissue-based assays.
Categories:
Health Care
Website:
http://www.regenemed.com

Company Details

Update

RegeneMed accelerates the development of safer, more effective drugs by providing integrated high throughput platforms incorporating engineered human tissue-based assays. Their patented, proprietary, core technologies enable in vitro growth of engineered human tissues, including liver, GI tract, bone marrow, blood-brain barrier, cardiovascular and neuronal. The first and critical application of these tissue-based in vitro model systems is to replace cell-based assays and animal testing to debottleneck ADME/Tox evaluation, the leading cause of drug failures facing the pharmaceutical industry.

Funding Rounds (1) - $1M

Update

Investors (1)

Update

Offices/Locations (1)

Update
  • Office

    9855 Towne Centre Drive

    Suite 200

    San Diego, CA 92121

    USA

News (1)

Update

    Images (1)

    Update
    • 8224794fd2e2e0b70d33ecda93fb4d32